Scientists from the Max Planck Institute for Biology of Ageing in Cologne discover serine as the hitherto unknown amino acid for protein modification, changing a 50-year-old paradigm.
Scientific achievements enlarge our knowledge about how things work and eventually enable us to understand details and even to predict the unknown.
Chemical structure of the amino acid serine, which is part of almost all proteins and the main target for ADP ribosylation. In the background a membrane with stained proteins.
©Max Planck Institute for Biology of Ageing
But sometimes the assumptions we make based on what we have already seen limit our perception and bias our approach to the new. This is exactly what happened with ADP ribosylation (ADPr), a particular protein modification that appears in every cell and is essential for almost all biological processes.
When a protein gets ADP ribosylated, it gets labeled with additional information. For example, an ADPr signal can be placed on a protein for the recruitment of vital factors to repair damaged DNA, the genetic information in cells. Like an alarm in case of an emergency, it marks the place where help is needed.
For half a century it was believed that ADPr modifies particular sites on proteins: the amino acids glutamate, aspartate, arginine and lysine. But the functional characterization of these identified sites showed very slow progress.
“We know the reason for this now: most of the sites were mis-localised” says Orsolya Leidecker, a scientist in the group of Dr. Ivan Matić from the Max Planck Institute for Biology of Ageing. Now the scientists have finally identified the amino acid serine as the major site of ADPr by using a new technique. Due to its chemical structure, serine was never really considered as a target, which makes this finding all the more exciting.
“It’s a little like the discovery of the structure of the DNA”, explains group leader Dr. Ivan Matić. “People had known for decades that there must be genetic information stored somewhere but didn’t know where or how. The field of ADPr modification was similarly slow to develop for lack of precise knowledge about which amino acid ADPr attaches to. Now we finally know exactly where this information sits.”
Additionally, the Matić group and their collaborators in Oxford have developed a simple method for validating serine ADP-ribosylated sites in cells, which enables any scientist to examine ADPr on their protein of interest. “Anybody in any lab can perform the experiment and investigate if the modification of their protein is on serine” says Leidecker, who contributed to the main part of the work.
Actually, the identification of the correct position of ADPr is only the beginning. Researchers can now investigate the impact of ADPr on proteins, understand their functionality and develop strategies to use this modification as a target for drug development. Targeting processes regulated by ADPr is already a very promising strategy in treatment of cancer and acute cardiovascular conditions.
The research was performed in collaboration with CECAD.
Dr. Annegret Burkert | Max-Planck-Institut für Biologie des Alterns
Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel
Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences